Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Autologous Tumor Lysate-pulsed DC-CIK Cell in Colorectal Cancer After Surgery

NCT02202928 is registered in ClinicalTrials.gov with Shenzhen Hornetcorn Bio-technology Company, LTD as lead sponsor.

NCT NCT02202928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02202928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Autologous Tumor Lysate-pulsed DC-CIK Cell in Colorectal Cancer After Surgery
Lead sponsor
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2014
Completion date
December 31, 2017
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, digestive system neoplasms, gastrointestinal diseases, intestinal neoplasms, neoplasms